108 studies found for:    Open Studies | "Pituitary Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pituitary Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy;   Pituitary Disease;   Thyroid Disease
Intervention: Drug: TRH (Thyrotropin Releasing Hormone)
2 Recruiting Pituitary Steroid Study
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
3 Not yet recruiting Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Conditions: Pituitary Neoplasms;   Prolactinoma;   ACTH-Secreting Pituitary Adenoma;   Gigantism;   Growth Hormone-Secreting Pituitary Adenoma
Intervention: Other: Educational Intervention
4 Available An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide long acting release formulation
5 Recruiting Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
6 Recruiting A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: somatropin
7 Recruiting Phase II Study With ITF2984 in Acromegalic Patients
Condition: Active Acromegaly
Interventions: Drug: Octreotide;   Drug: ITF2984 500 mcg;   Drug: ITF2984 1000 mcg;   Drug: ITF2984 2000 mcg
8 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Intervention:
9 Recruiting Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: Pasireotide;   Drug: Cabergoline
10 Recruiting Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device
Conditions: Growth Hormone Deficiency;   Turner's Syndrome
Intervention: Drug: somatropin
11 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
12 Recruiting The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
Conditions: Metabolism;   Insulin Resistance;   Hypopituitarism
Interventions: Drug: Acipimox;   Drug: Ghrelin;   Other: Placebo
13 Recruiting Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
Condition: Schizophrenia
Intervention: Drug: Aripiprazole
14 Recruiting Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Condition: Pituitary Tumor
Intervention:
15 Recruiting Somatuline Predictive Factors in Acromegaly and NET
Conditions: Acromegaly;   Neuroendocrine Tumours
Intervention: Drug: Somatuline Autogel® 60, 90 or 120 mg
16 Unknown  Genome-wide Association Study of Pituitary Tumors
Condition: Pituitary Adenomas
Intervention:
17 Recruiting Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
Condition: Acromegaly
Intervention:
18 Unknown  The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
Condition: Pituitary Adenomas
Intervention:
19 Recruiting Characterization of Receptors in Non-functioning Pituitary Macroadenomas
Condition: Pituitary Tumor
Intervention: Other: To perform RT-PCR on the tissue obtained during surgery
20 Recruiting Versartis Long-Term Extension Study of VRS-317
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: VRS-317

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years